Literature DB >> 17705091

Outcome of posthepatectomy-missing colorectal liver metastases after complete response to chemotherapy: impact of adjuvant intra-arterial hepatic oxaliplatin.

Dominique Elias1, Diane Goere, Valérie Boige, Niaz Kohneh-Sharhi, David Malka, Gorana Tomasic, Clarisse Dromain, Michel Ducreux.   

Abstract

BACKGROUND: Dramatic responses to chemotherapy are occurring more and more frequently in patients with multiple colorectal liver metastases (LMs), leading to resection. In a few patients, some LMs vanish on imaging studies, remain undetected during hepatectomy, and are left in place, which defines the "missing LMs." The aim of our study was to assess the long-term outcome of such "missing LMs." PATIENTS: Between January 1999 and June 2004, among 228 patients treated for colorectal LMs, missing LMs were observed in 16 patients. All the patients were operated within 4 weeks of imaging. Hepatic arterial infusion (HAI) with oxaliplatin was administrated in 12 patients (75%): seven before hepatectomy and five after.
RESULTS: Overall, 69 missing LMs were diagnosed and left in place. Among the persistent LMs resected, a complete pathological response was significantly more often observed in the group with preoperative HAI (6 of 7), than in the group without (2 of 9, P < .02). With a mean follow-up of 51 months (24-90), missing LMs did not reappear in 10 patients (62%). Adjuvant HAI was significantly correlated with the definitive eradication of missing LMs (P < .01), as it was not a complete pathological response. The overall 3-year survival rate of these highly selected 16 patients was 94%.
CONCLUSION: Colorectal LMs under chemotherapy that vanish on high-quality imaging studies, remain undetected during hepatectomy, and are left in place, are definitively cured in 62% of cases. This excellent result seems to be due to the administration of adjuvant hepatic arterial infusion of chemotherapy and should stimulate new investigations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17705091     DOI: 10.1245/s10434-007-9482-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  32 in total

Review 1.  "Vanishing liver metastases"-A real challenge for liver surgeons.

Authors:  Alex Zendel; Eylon Lahat; Yael Dreznik; Barak Bar Zakai; Rony Eshkenazy; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Augmented Reality Guidance for the Resection of Missing Colorectal Liver Metastases: An Initial Experience.

Authors:  Dimitrios Ntourakis; Ricardo Memeo; Luc Soler; Jacques Marescaux; Didier Mutter; Patrick Pessaux
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

Review 3.  A systematic review and meta-analysis to reappraise the role of adjuvant hepatic arterial infusion for colorectal cancer liver metastases.

Authors:  Wei Liu; Qing-Kun Song; Bao-Cai Xing
Journal:  Int J Colorectal Dis       Date:  2015-05-27       Impact factor: 2.571

4.  Disappearing or residual tiny (≤5 mm) colorectal liver metastases after chemotherapy on gadoxetic acid-enhanced liver MRI and diffusion-weighted imaging: Is local treatment required?

Authors:  Seung Soo Kim; Kyoung Doo Song; Young Kon Kim; Hee Cheol Kim; Jung Wook Huh; Young Suk Park; Joon Oh Park; Seung Tae Kim
Journal:  Eur Radiol       Date:  2016-11-04       Impact factor: 5.315

Review 5.  Colorectal cancer with liver metastases: neoadjuvant chemotherapy, surgical resection first or palliation alone?

Authors:  Khurum Khan; Anita Wale; Gina Brown; Ian Chau
Journal:  World J Gastroenterol       Date:  2014-09-21       Impact factor: 5.742

6.  What is the potential role of hepatic arterial infusion chemo-therapy in the current armamentorium against colorectal cancer.

Authors:  Ozkän Kanat; Alexandra Gewirtz; Nancy Kemeny
Journal:  J Gastrointest Oncol       Date:  2012-06

Review 7.  Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases.

Authors:  Alexandre Doussot; Nancy E Kemeny; Michael I D'Angelica
Journal:  Hepat Oncol       Date:  2015-07-27

Review 8.  Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.

Authors:  Mathias Worni; Kevin N Shah; Bryan M Clary
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

Review 9.  The effects of cancer chemotherapy on liver imaging.

Authors:  Philip J A Robinson
Journal:  Eur Radiol       Date:  2009-02-24       Impact factor: 5.315

10.  Prospective diagnostic test accuracy comparison of computed tomography during arterial portography and Primovist magnetic resonance imaging in the pre-operative assessment of colorectal cancer liver metastases.

Authors:  Jai S Bagia; Alan Chai; Roger Chou; Christopher Chu; John Rouse; Elizabeth Sinclair; Leon Vonthethoff; Armando Teixeira-Pinto
Journal:  HPB (Oxford)       Date:  2015-08-10       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.